Kind of sad when you think about it that everybody wants to think that their pet OTC stock is unique or “special” in some way (either amazingly great or horribly bad) when the sad reality is that there is a dreary sameness to all OTC subpennies. They will all dilute, because the only way to generate capital is to sell shares. It’s a pointless exercise to attempt to establish any particular ticker is “better” or “worse” than any other, because tomorrow an entire host of equally qualified candidates will show up. What we have here in HUMBL is pitifully common. Common as dirt.
News 
Market Data 
Discover 
